SCHEMBL15026117

SCHEMBL15026117

CCOC(=O)c1cn(CCO[Si](C)(C)C(C)(C)C)nc1N(C)C(=O)C(F)(F)F

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TEAD2 Q15562 1/20 0.33
▸ JUN P05412 2/20 0.32
▸ NFKB1 P19838 2/20 0.32
▸ NFKB2 Q00653 2/20 0.32
▸ RELA Q04206 2/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ FOS P01100 1/20 0.32
▸ ADORA3 P0DMS8 1/20 0.31
▸ ADORA2A P29274 1/20 0.31
▸ ADORA1 P30542 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ GAA P10253 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ CASP1 P29466 1/20 0.31
▸ KLK7 P49862 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ HDAC4 P56524 1/20 0.31
▸ HDAC6 Q9UBN7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12429194 0.81 TEAD2 (0.36) TEAD2JUNNFKB1NFKB2RELA
SCHEMBL15026118 0.79 TRPM8 (0.41) TEAD2JUNNFKB1NFKB2RELA
SCHEMBL15026119 0.79 TEAD2 (0.39) TEAD2CYP2C19ADORA3ADORA2AADORA1
SCHEMBL15026115 0.77 KDM4E (0.38) TEAD2JUNNFKB1NFKB2RELA
SCHEMBL18149668 0.71 FOS (0.38) JUNNFKB1NFKB2RELACYP3A4
SCHEMBL13860366 0.69 L3MBTL1 (0.43) CYP3A4CYP2C19ALDH1A1KDM4EHPGD
SCHEMBL21809657 0.67 KMT2A (0.37) CYP3A4ALDH1A1KDM4EGAAHPGD
SCHEMBL21408417 0.66 GAA (0.46) TEAD2JUNNFKB1NFKB2RELA
SCHEMBL15273722 0.65 ALDH1A1 (0.43) CYP3A4CYP2C19ALDH1A1GAARAB9A
SCHEMBL6077974 0.65 KMT2A (0.38) CYP3A4CYP2C19ADORA3ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130150350-A1 Derivatives of 1-Phenyl-1,5-Dihydro-Benzo[B] [1,4]Diazepine-2,4-Dione as Inhibitors of HIV Replication BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130150350-A1 Derivatives of 1-Phenyl-1,5-Dihydro-Benzo[B] [1,4]Diazepine-2,4-Dione as Inhibitors of HIV Replication MED1, ZC3HAV1, BET1 TEAD2 1637/4885JUN 933/4885NFKB1 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback